A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

Most anticancer drugs entering clinical trials fail to achieve approval from the US FDA. Drug development is hampered by the lack of preclinical models with therapeutic predictive value. Herein, we report the development and validation of a tumorgraft model of renal cell carcinoma (RCC) and its appl...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sivanand, Sharanya, Peña-Llopis, Samuel, Zhao, Hong, Kucejova, Blanka, Spence, Patrick, Pavia-Jimenez, Andrea, Yamasaki, Toshinari, McBride, David J., Gillen, Jessica, Wolff, Nicholas C., Morlock, Lorraine, Lotan, Yair, Raj, Ganesh V., Sagalowsky, Arthur, Margulis, Vitaly, Cadeddu, Jeffrey A., Ross, Mark T., Bentley, David R., Kabbani, Wareef, Xie, Xian-Jin, Kapur, Payal, Williams, Noelle S., Brugarolas, James
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2012
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570965/
https://ncbi.nlm.nih.gov/pubmed/22674553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3003643
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk